small-logo
ProfessionalsCapabilitiesInsights & NewsCareersLocations
About UsAlumniOpportunity & InclusionPro BonoCorporate Social Responsibility
Stay Connected:
facebookinstagramlinkedintwitteryoutube
Site Search
  • Professionals (901)
  • Capabilities (87)
  • Experience (141)
  • Insights & News (3,724)
  • Other Results (71)

Professionals 901 results

Michael Mullins
Michael Mullins
Partner
  • Chicago
Email
+1 312-558-7568
vCard

Partner

  • Chicago
David Baroni
David Baroni
Partner
  • Chicago
Email
+1 312-558-5851
vCard

Partner

  • Chicago
Samantha Lerner
Samantha Lerner
Partner
  • Chicago
Email
+1 312-558-6463
vCard

Partner

  • Chicago
View All Professionals

Capabilities 87 results

Practice Area

Structured Finance

Our structured finance group is widely recognized as a leader, encompassing Esoteric Finance, Residential Asset Finance and Securitization, and CLOs/Fund Finance. Positioned prominently at the forefront of the industry, our team boasts extensive experience across a broad spectrum of assets, with a particular focus on bespoke structures and emerging and/or “esoteric” assets, including residential and commercial PACE, RMBS, and CMBS; aircraft, vessel, and railcar finance; FinTech and marketplace lending; CLOs; specialty finance; consumer and business lending; energy structured finance (including solar finance and reserve-based finance); derivatives and structured products; lease and operating asset finance; trade receivables; litigation settlement financing; and life settlements....Read more

Practice Area

Project Finance

Practice Area

Debt Finance

Winston’s Debt Finance team focuses on all aspects of leveraged finance and asset-based lending both internationally and domestically. Our clients include leading international investment banks, commercial banks, direct lenders, credit funds, insurance companies, CLOs, and other institutional investors, as well as private equity funds, hedge funds, and corporations. ...Read more

Experience 141 results

Experience

|

September 23, 2025

Denali Capital Acquisition Corp Closes Business Combination with Semnur Pharmaceuticals

Winston & Strawn LLP represented Denali Capital Acquisition Corp. (OTCQB: DNQAF), a special purpose acquisition company, in the closing of its previously announced business combination with Semnur Pharmaceuticals, Inc., a clinical late-stage specialty pharmaceutical company focused on the development and commercialization of novel non-opioid pain therapies and a majority-owned subsidiary of Scilex Holding Company (Nasdaq: SCLX).  ...Read more

Experience

|

September 8, 2025

Winston Wins Ninth Circuit Reversal and Class Certification in Swimmers’ Antitrust Case, Securing a Global-Impact Settlement with World Aquatics

Winston represents a class of professional swimmers alleging World Aquatics (WA) violated antitrust laws by blocking their participation in the competing  International Swimming League. After WA won summary judgment, Winston successfully appealed, arguing the court applied improper antitrust standards and wrongly denied certification of a damages class. In September 2024, the Ninth Circuit reversed both rulings, reviving all claims and issuing a landmark ruling on the possible application of the per se rule or quick look review to sports-associations rules. Am Law awarded Winston “Litigator of the Week” Runner-Up recognition for the win. In November 2024, the Ninth Circuit denied rehearing. In April 2025, the district court certified a damages class....Read more

Experience

|

August 18, 2025

Winston Represented Amphenol in Definitive Agreement to Acquire Trexon

Winston represented Amphenol Corporation (NYSE: APH), one of the world’s largest designers, manufacturers, and marketers of electrical, electronic, and fiber optic connectors and systems, as well as coaxial and high-speed specialty cables, in its definitive agreement to acquire Trexon, a leading provider of high-reliability interconnect and cable assemblies primarily serving the defense market. The acquisition is valued at approximately US$1B, subject to customary post-closing adjustments. Amphenol will finance the transaction with cash on hand and expects to close in the fourth quarter of 2025....Read more
View All Experience

Insights & News 3,724 results

Sponsorship

|

November 20, 2025

Winston & Strawn Sponsors 2025 Smart Business Dealmakers South Florida M&A Conference

Winston & Strawn is proud to sponsor the upcoming Smart Business Dealmakers South Florida M&A Conference. The conference brings together hundreds of local dealmakers, including middle-market CEOs, top investors and lenders, and leading M&A advisers....Read more

Sponsorship

|

November 12, 2025

Winston & Strawn Sponsors 2025 Smart Business Dealmakers Houston M&A Conference

Winston & Strawn is proud to sponsor the upcoming Smart Business Dealmakers Houston M&A Conference. The conference will discuss topics ranging from raising capital to alternative asset investing, covering the breadth of the M&A landscape....Read more

Recognitions

|

October 31, 2025

|

1 Min Read

Winston & Strawn Ranked in 2025 Chambers Brazil: Transactional Guide

Winston & Strawn has been recognized in the 2025 edition of Chambers Brazil: Transactional Guide. Chambers Brazil ranks and reviews the top law firms and lawyers in Brazil based on in-depth research and client feedback across key practice areas and industry sectors. The firm was ranked for its strength in the following international firm practice areas:...Read more
View All Insights & News

Other Results 71 results

Site Content

What Is ESG in Finance?

ESG in finance can refer to, among other things, financing tools such as Green, Social, and Sustainability Bonds and similar ESG-related debt instruments, as well as the separate discipline of ESG Investing. ESG stands for Environmental, Social, and Governance. Investors are increasingly applying these non-financial factors as part of their analysis to identify ESG-related risks and opportunities in particular investments. ESG metrics have not historically been included in financial reporting, though companies are increasingly making disclosures in their annual report or in a standalone sustainability report, and regulatory requirements for such disclosures, including from the SEC, are expanding....Read more

Site Content

Associate Salary Disclosures

Law Glossary

What Exclusivity Periods Are Associated with Biosimilars?

An applicant may not submit an aBLA until four years after the reference product is licensed by the FDA. (See BPCIA § 351(k).) Further, any biosimilar licenses “may not be made effective” until 12 years after the reference product was licensed. (See BPCIA § 351(l).)...Read more
Logo
facebookinstagramlinkedintwitteryoutube

Copyright © 2025. Winston & Strawn LLP

AlumniCorporate Transparency Act Task ForceDEI Compliance Task ForceEqual Rights AmendmentLaw GlossaryThe Oval UpdateWinston MinutePrivacy PolicyCookie PolicyFraud & Scam AlertsNoticesSubscribeAttorney Advertising